President @ ImmunoACT | Health Economist & Market Access Leader | Cell & Gene Therapy | AI & Technology Enthusiast
Current: New
No active campaigns
simpson@immunoact.com
Located in target market India but ImmunoACT appears to be a cell & gene therapy biotech company rather than a clinic or EMR/health IT vendor. Title 'President' suggests leadership role but in pharmaceutical/biotech space rather than clinical operations or health IT partnerships. No engagement data provided and industry focus doesn't align strongly with ZAVIS's clinic-focused patient engagement platform.